Regulatory

RSS

Watson's first NDA product approved

Jan. 3, 1997

Two FDA approvals for Taro

Jan. 3, 1997

Lipid effects of two gestodene/ethinylestradiol combinations compared

Jan. 3, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

FDA clears oral monotherapy for PID

Dec. 31, 1996

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Andrx licenses chemoprotective agent to Asta

Dec. 30, 1996